Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenling Baizhu capsules are a Traditional Chinese Medicine (TCM) formulation based on the classic "Shenling Baizhu San" recipe, which dates back to the Song Dynasty. The formula is composed of ten primary herbal ingredients: Panax ginseng (Ren Shen), Poria cocos (Fu Ling), Atractylodes macrocephala (Bai Zhu), Dioscorea opposita (Shan Yao), Lablab purpureus (Bian Dou), Nelumbo nucifera (Lian Zi), Coix lacryma-jobi (Yi Yi Ren), Amomum villosum (Sha Ren), Platycodon grandiflorus (Jie Geng), and Glycyrrhiza uralensis (Gan Cao). It is traditionally used to tonify the Spleen, replenish Qi, and transform dampness, making it a standard treatment for Spleen-deficiency-related gastrointestinal issues such as chronic diarrhea and poor appetite. In modern clinical research, it is being investigated for its potential to prevent relapse and reduce proteinuria in patients with minimal change disease (MCD), often in combination with other TCM therapies like Bupi Yishen granules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenling baizhu capsules.